Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial

BACKGROUND: Agitation is common in people with dementia and negatively affects the quality of life of both people with dementia and carers. Non-drug patient-centred care is the first-line treatment, but there is a need for other treatment when this care is not effective. Current evidence is sparse o...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Sube, High, Juliet, Stirling, Susan, Shepstone, Lee, Swart, Ann Marie, Telling, Tanya, Henderson, Catherine, Ballard, Clive, Bentham, Peter, Burns, Alistair, Farina, Nicolas, Fox, Chris, Francis, Paul, Howard, Robert, Knapp, Martin, Leroi, Iracema, Livingston, Gill, Nilforooshan, Ramin, Nurock, Shirley, O'Brien, John, Price, Annabel, Thomas, Alan J, Tabet, Naji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546216/
https://www.ncbi.nlm.nih.gov/pubmed/34688369
http://dx.doi.org/10.1016/S0140-6736(21)01210-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546216/
https://www.ncbi.nlm.nih.gov/pubmed/34688369
http://dx.doi.org/10.1016/S0140-6736(21)01210-1

Ejemplares similares